Revolution Medicines, Warrant Stock Today
| RVMDW Stock | 0.35 0.01 2.50% |
Performance16 of 100
| Odds Of DistressOver 56
|
Revolution Medicines, is selling for under 0.351 as of the 2nd of December 2024; that is 2.5 percent down since the beginning of the trading day. The stock's lowest day price was 0.35. Revolution Medicines, has over 56 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat solid returns during the last 90 days. Equity ratings for Revolution Medicines, Warrant are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of November 2023 | Category Healthcare | Classification Health Care |
Revolution Medicines, is entity of United States. It is traded as Stock on NASDAQ exchange. More on Revolution Medicines, Warrant
Moving against Revolution Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Revolution Stock Highlights
| President CEO | Mark Goldsmith | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revolution Medicines, can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Revolution Medicines,'s financial leverage. It provides some insight into what part of Revolution Medicines,'s total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revolution Medicines, Warrant (RVMDW) is traded on NASDAQ Exchange in USA. It is located in 700 Saginaw Drive, Redwood City, CA, United States, 94063 and employs 490 people. Revolution Medicines, is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Revolution Medicines, generates negative cash flow from operations
Check Revolution Medicines, Probability Of Bankruptcy
Revolution Medicines, Historical Income Statement
Revolution Stock Against Markets
Revolution Medicines, Corporate Management
| Jack Anders | Chief Officer | Profile | |
| Erin Graves | Senior Relations | Profile | |
| Walter Reiher | Chief Officer | Profile | |
| Margaret JD | Chief Officer | Profile | |
| Michael Fischbach | Academic Board | Profile |
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.